July 28, 2020

FDA authorizes first COVID-19 diagnostic test for screening asymptomatic people

By: Judy Mathias

Editor's Note

The Food and Drug Administration (FDA) on July 24 reissued its emergency use authorization (EUA) for LabCorp’s COVID-19 RT-PCR Test to include two new indications for use:

  • Testing for individuals who do not have COVID-19 symptoms or who have no reason to suspect COVID-19 infection.
  • Allowing for pooled sample testing with up to five individual specimens.

Sponsored Message

The FDA previously issued an EUA of the test for those with suspected COVID-19 and individual specimens.

“The FDA’s authorization of the first diagnostic test to be used for anyone, regardless of whether they are showing symptoms of COVID-19 or have other exposure risk factors, is a step toward the type of broad screening that may help enable the reopening of schools and workplaces,” says FDA Commissioner Stephen M. Hahn, MD.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Live chat by BoldChat